You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
One medication can reduce blood pressure by 5.1 mmHg over 12 months.1 Of course, this can be difficult to achieve because 50% of all patients become non-adherent within that time frame.2
Small changes can make a big difference in a patient’s life. In this case, just a 5 mmHg reduction in blood pressure can reduce the risk of major adverse cardiovascular events by 10%.1
All categories experience the same relative risk reduction, including patients with normal or elevated blood pressure, those in stage 1 or 2, and those experiencing hypertensive crisis.1
This quiz is inspired by findings from “Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure,” which was published in The Lancet.1
Use our resources, tools, and insights to start a dedicated hypertension program.
Rahimi K, Bidel Z, Nazarzadeh M, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. The Lancet. 2021 397; 1625-362
Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. Hypertension. April 2013;31(4):766–774.